SC
MED icon

Scotia Capital’s Medifast MED Stock Holding History

Scotia Capital’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,473
Closed -$266K – 818
2022
Q2 		$266K Buy
1,473
+4
+0.3% +$716 ﹤0.01% 678
2022
Q1 		$251K Buy
1,469
+2
+0.1% +$377 ﹤0.01% 764
2021
Q4 		$307K Buy
1,467
+55
+4% +$11.4K ﹤0.01% 732
2021
Q3 		$272K Buy
1,412
+257
+22% +$63.2K ﹤0.01% 745
2021
Q2 		$327K Sell
1,155
-747
-39% -$202K ﹤0.01% 704
2021
Q1 		$403K Sell
1,902
-354
-16% -$84.7K ﹤0.01% 641
2020
Q4 		$443K Sell
2,256
-444
-16% -$78.5K ﹤0.01% 585
2020
Q3 		$444K Sell
2,700
-356
-12% -$58.6K ﹤0.01% 530
2020
Q2 		$424K Sell
3,056
-426
-12% -$39.1K 0.01% 451
2020
Q1 		$218K Sell
3,482
-135
-4% -$12.3K ﹤0.01% 561
2019
Q4 		$396K Buy
3,617
+157
+5% +$15.2K ﹤0.01% 562
2019
Q3 		$359K Buy
+3,460
New +$372K ﹤0.01% 574

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Scotia Capital's MED Position: Q3 2022 in Review

Scotia Capital sold out of Medifast (MED) in Q3 2022, closing a stake of 1,473 shares — an estimated $266K sold.

Scotia Capital first reported a position in MED in Q3 2019 and held it in 12 quarters. The position peaked at $444K in Q3 2020. 263 funds tracked by Wall St. Rank hold MED as of Q3 2022.

  • Scotia Capital reported no remaining Medifast position as of Q3 2022 after selling out during the quarter.
  • Scotia Capital sold 1,473 Medifast shares in Q3 2022, an estimated $266K.
  • Scotia Capital first reported a position in Medifast in Q3 2019 and held it in 12 quarters.
  • Scotia Capital's Medifast position peaked at $444K in Q3 2020.
  • 263 funds tracked by Wall St. Rank held Medifast as of Q3 2022.

Based on Scotia Capital's 13F filing for Q3 2022, filed 10 Nov 2022.